首页 > 最新文献

Revista Espanola De Medicina Nuclear E Imagen Molecular最新文献

英文 中文
Modelo para predecir riesgo de fallecimiento de causa cardíaca según características clínicas y parámetros del gated-SPECT de perfusión miocárdica 根据临床特征和心肌灌注Gate -SPECT参数预测心脏死亡风险的模型
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-09-01 Epub Date: 2025-04-03 DOI: 10.1016/j.remn.2025.500132
G. Rodríguez Cabalé , E. Rodríguez Cabalé , V. Pubul Núñez , Á. Ruibal Morell

Background

Coronary artery disease is a complex, multifactorial process with high prevalence and morbidity-mortality. Single photon emission computed tomography (SPECT) myocardial perfusion imaging synchronized with the electrocardiogram (gated-SPECT) is a non-invasive imaging technique that has demonstrated high sensitivity and specificity for diagnosis and staging. To better predict the risk of adverse events, it is necessary to analyze the simultaneous behavior of clinical elements and diagnostic tests, a type of study that is scarce in the current literature. This research evaluated the relationship between clinical characteristics and gated-SPECT myocardial perfusion parameters with progression to cardiac death; subsequently, a model was built to predict the risk of such an outcome.

Methods

An observational, longitudinal, and retrospective study was conducted with 2 230 patients who underwent this test due to suspected coronary artery disease. Clinical characteristics, test parameters, and progression to cardiac death were collected and the relationships between them were studied. A logistic regression model was built to study the relationships between the variables and their influence on the probability of progression to cardiac death.

Results

Clinical characteristics associated with a higher probability of cardiac death were male sex (OR = 5.104, P = 0.004), peripheral arterial disease (OR = 7.175, P < 0.001), and diabetes mellitus (OR = 3.159, P = 0.013). The gated-SPECT parameters associated with a higher risk of this outcome were VTS ≥70 ml (OR = 12.257, P < 0.001), EF < 50% (OR = 10.757, P < 0.001), VTD ≥140 ml (OR = 8.884, P < 0.001), ventricular dilation (OR = 8.959, P < 0.001), and reversible defects (OR = 7.454, P = 0.001). Fixed defects, parietal motility abnormalities, the presence of both reversible and fixed defects, and the hyperdynamic gated state were also associated with a higher risk of cardiac death but with lower ORs.
The logistic regression model showed good overall performance and high ability to determine progression to cardiac death, close to perfect predictive capacity (AUC = 0.9656).

Conclusions

It is necessary to employ total cardiovascular risk models that include results from diagnostic tests such as gated-SPECT. The constructed model demonstrated good overall performance and is a valid proposal for predicting the risk of death due to cardiac causes.
背景冠状动脉疾病是一个复杂的、多因素的过程,具有高患病率和发病率-死亡率。单光子发射计算机断层扫描(SPECT)与心电图同步心肌灌注成像(门控SPECT)是一种非侵入性成像技术,在诊断和分期方面具有很高的灵敏度和特异性。为了更好地预测不良事件的风险,有必要分析临床因素和诊断试验的同时行为,这是目前文献中很少的一类研究。本研究评估临床特征和门控spect心肌灌注参数与心源性死亡进展的关系;随后,建立了一个模型来预测这种结果的风险。方法对2 230例疑似冠状动脉疾病患者进行观察性、纵向和回顾性研究。收集临床特征、试验参数及心源性死亡进展情况,并研究它们之间的关系。建立logistic回归模型,研究各变量之间的关系及其对心源性死亡进展概率的影响。结果男性(OR = 5.104, P = 0.004)、外周动脉疾病(OR = 7.175, P < 0.001)和糖尿病(OR = 3.159, P = 0.013)与心源性死亡概率较高相关。与该结果较高风险相关的门控spect参数为VTS≥70 ml (OR = 12.257, P < 0.001)、EF < 50% (OR = 10.757, P < 0.001)、VTD≥140 ml (OR = 8.884, P < 0.001)、心室扩张(OR = 8.959, P < 0.001)和可逆缺陷(OR = 7.454, P = 0.001)。固定缺陷、顶叶运动异常、可逆缺陷和固定缺陷的存在以及高动力门控状态也与心脏死亡的高风险相关,但与较低的ORs相关。logistic回归模型整体表现良好,对心源性死亡进展的预测能力较高,接近完美预测能力(AUC = 0.9656)。结论采用包括门控spect等诊断试验结果在内的总心血管风险模型是必要的。所构建的模型整体性能良好,是预测心脏原因死亡风险的有效建议。
{"title":"Modelo para predecir riesgo de fallecimiento de causa cardíaca según características clínicas y parámetros del gated-SPECT de perfusión miocárdica","authors":"G. Rodríguez Cabalé ,&nbsp;E. Rodríguez Cabalé ,&nbsp;V. Pubul Núñez ,&nbsp;Á. Ruibal Morell","doi":"10.1016/j.remn.2025.500132","DOIUrl":"10.1016/j.remn.2025.500132","url":null,"abstract":"<div><h3>Background</h3><div>Coronary artery disease is a complex, multifactorial process with high prevalence and morbidity-mortality. Single photon emission computed tomography (SPECT) myocardial perfusion imaging synchronized with the electrocardiogram (gated-SPECT) is a non-invasive imaging technique that has demonstrated high sensitivity and specificity for diagnosis and staging. To better predict the risk of adverse events, it is necessary to analyze the simultaneous behavior of clinical elements and diagnostic tests, a type of study that is scarce in the current literature. This research evaluated the relationship between clinical characteristics and gated-SPECT myocardial perfusion parameters with progression to cardiac death; subsequently, a model was built to predict the risk of such an outcome.</div></div><div><h3>Methods</h3><div>An observational, longitudinal, and retrospective study was conducted with 2 230 patients who underwent this test due to suspected coronary artery disease. Clinical characteristics, test parameters, and progression to cardiac death were collected and the relationships between them were studied. A logistic regression model was built to study the relationships between the variables and their influence on the probability of progression to cardiac death.</div></div><div><h3>Results</h3><div>Clinical characteristics associated with a higher probability of cardiac death were male sex (OR<!--> <!-->=<!--> <!-->5.104, <em>P</em> <!-->=<!--> <!-->0.004), peripheral arterial disease (OR<!--> <!-->=<!--> <!-->7.175, <em>P</em> <!-->&lt;<!--> <!-->0.001), and diabetes mellitus (OR<!--> <!-->=<!--> <!-->3.159, <em>P</em> <!-->=<!--> <!-->0.013). The gated-SPECT parameters associated with a higher risk of this outcome were VTS ≥70<!--> <!-->ml (OR<!--> <!-->=<!--> <!-->12.257, <em>P</em> <!-->&lt;<!--> <!-->0.001), EF &lt;<!--> <!-->50% (OR<!--> <!-->=<!--> <!-->10.757, <em>P</em> <!-->&lt;<!--> <!-->0.001), VTD ≥140<!--> <!-->ml (OR<!--> <!-->=<!--> <!-->8.884, <em>P</em> <!-->&lt;<!--> <!-->0.001), ventricular dilation (OR<!--> <!-->=<!--> <!-->8.959, <em>P</em> <!-->&lt;<!--> <!-->0.001), and reversible defects (OR<!--> <!-->=<!--> <!-->7.454, <em>P</em> <!-->=<!--> <!-->0.001). Fixed defects, parietal motility abnormalities, the presence of both reversible and fixed defects, and the hyperdynamic gated state were also associated with a higher risk of cardiac death but with lower ORs.</div><div>The logistic regression model showed good overall performance and high ability to determine progression to cardiac death, close to perfect predictive capacity (AUC<!--> <!-->=<!--> <!-->0.9656).</div></div><div><h3>Conclusions</h3><div>It is necessary to employ total cardiovascular risk models that include results from diagnostic tests such as gated-SPECT. The constructed model demonstrated good overall performance and is a valid proposal for predicting the risk of death due to cardiac causes.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 5","pages":"Article 500132"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144908667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicción de la respuesta completa a la quimiorradioterapia neoadyuvante en el cáncer de recto localmente avanzado: papel de los parámetros volumétricos basales de la PET/TC con [18F]FDG y los marcadores inflamatorios 预测局部晚期直肠癌新辅助化疗的完全反应:使用[18F]FDG和炎症标志物的PET/ CT基本体积参数的作用
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-09-01 Epub Date: 2025-06-02 DOI: 10.1016/j.remn.2025.500113
G.U. Erdem , O. Vural Topuz , E. Acar , T. Kapagan , E. Yetim , A. Ozmen , S. Gurocak , G. Usul , S. Yuksel , A.H. Yardimci , N. Bulut

Objectives

We evaluated the influence of baseline volumetric 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) parameters and inflammatory prognostic markers on complete response (CR) in patients with locally advanced rectal cancer (LARC) treated with neoadjuvant chemoradiotherapy (nCRT).

Materials and methods

In total, 90 patients with LARC, including those with and without CR, were evaluated based on baseline volumetric PET/CT parameters, such as maximum standard uptake value, metabolic tumor volume (MTV), tumor lesion glycolysis, and inflammatory prognostic markers, including the lymphocyte-to-monocyte ratio, platelet-to-lymphocyte ratio (PLR), and neutrophil-to-lymphocyte ratio.

Results

Of the 90 patients, 62 (68.9%) were male and 28 (31.1%) were female. The median age was 61 (31-81) years. A complete response was observed in 20 (22%) patients following nCRT. Of these, 5 demonstrated a clinical complete response, whereas 15 exhibited a complete response after surgery. A low pretreatment PLR, low MTV levels, and stage 2 disease were identified as significant predictors of complete response. The optimal cutoff values were 16.5 for MTV (sensitivity 80%, specificity 62%) and 121 for PLR (sensitivity 73%, specificity 65%).

Conclusion

Our findings suggest that stage 2 disease, low pretreatment MTV, and low PLR levels may be predictive of a CR to nCRT in patients with LARC.
目的评估基线容量18f -氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(18F-FDG PET/CT)参数和炎症预后标志物对局部晚期直肠癌(LARC)接受新辅助放化疗(nCRT)患者完全缓解(CR)的影响。材料和方法共90例LARC患者,包括伴有和不伴有CR的患者,根据PET/CT的基线体积参数进行评估,如最大标准摄取值、代谢肿瘤体积(MTV)、肿瘤病变糖酵解和炎症预后指标,包括淋巴细胞与单核细胞比值、血小板与淋巴细胞比值(PLR)和中性粒细胞与淋巴细胞比值。结果90例患者中,男性62例(68.9%),女性28例(31.1%)。中位年龄为61岁(31-81岁)。20例(22%)患者在nCRT后完全缓解。其中5例临床完全缓解,15例术后完全缓解。低预处理PLR、低MTV水平和2期疾病被认为是完全缓解的重要预测因素。MTV的最佳截止值为16.5(灵敏度80%,特异性62%),PLR的最佳截止值为121(灵敏度73%,特异性65%)。结论我们的研究结果表明,2期疾病、低预处理MTV和低PLR水平可能预示着LARC患者的CR到nCRT。
{"title":"Predicción de la respuesta completa a la quimiorradioterapia neoadyuvante en el cáncer de recto localmente avanzado: papel de los parámetros volumétricos basales de la PET/TC con [18F]FDG y los marcadores inflamatorios","authors":"G.U. Erdem ,&nbsp;O. Vural Topuz ,&nbsp;E. Acar ,&nbsp;T. Kapagan ,&nbsp;E. Yetim ,&nbsp;A. Ozmen ,&nbsp;S. Gurocak ,&nbsp;G. Usul ,&nbsp;S. Yuksel ,&nbsp;A.H. Yardimci ,&nbsp;N. Bulut","doi":"10.1016/j.remn.2025.500113","DOIUrl":"10.1016/j.remn.2025.500113","url":null,"abstract":"<div><h3>Objectives</h3><div>We evaluated the influence of baseline volumetric 18F-fluorodeoxyglucose positron emission tomography/computed tomography (<sup>18</sup>F-FDG PET/CT) parameters and inflammatory prognostic markers on complete response (CR) in patients with locally advanced rectal cancer (LARC) treated with neoadjuvant chemoradiotherapy (nCRT).</div></div><div><h3>Materials and methods</h3><div>In total, 90 patients with LARC, including those with and without CR, were evaluated based on baseline volumetric PET/CT parameters, such as maximum standard uptake value, metabolic tumor volume (MTV), tumor lesion glycolysis, and inflammatory prognostic markers, including the lymphocyte-to-monocyte ratio, platelet-to-lymphocyte ratio (PLR), and neutrophil-to-lymphocyte ratio.</div></div><div><h3>Results</h3><div>Of the 90 patients, 62 (68.9%) were male and 28 (31.1%) were female. The median age was 61 (31-81) years. A complete response was observed in 20 (22%) patients following nCRT. Of these, 5 demonstrated a clinical complete response, whereas 15 exhibited a complete response after surgery. A low pretreatment PLR, low MTV levels, and stage 2 disease were identified as significant predictors of complete response. The optimal cutoff values were 16.5 for MTV (sensitivity 80%, specificity 62%) and 121 for PLR (sensitivity 73%, specificity 65%).</div></div><div><h3>Conclusion</h3><div>Our findings suggest that stage 2 disease, low pretreatment MTV, and low PLR levels may be predictive of a CR to nCRT in patients with LARC.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 5","pages":"Article 500113"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144908673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nuevo método de heterogeneidad para predecir la supervivencia en el cáncer de mama triple negativo no metastásico 预测非转移性三阴性乳腺癌生存率的新异质性方法
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-09-01 Epub Date: 2025-06-24 DOI: 10.1016/j.remn.2025.500112
G.B. Babacan , M.Ö. Tamam , S. Saraçoğlu , M.N. Acar Tayyar , M.C. Şahin , H. Özçevik , G. Kulduk , Ö.B. Ekinci , E. Çelik

Objective

This study aimed to investigate the relationship between semiquantitative positron emission tomography (PET) parameters and intratumoral heterogeneity (ITH) on 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) imaging and survival data of non-metastatic triple-negative breast cancer (TNBC) patients.

Methods

Sixty-two consecutive female patients who underwent pretreatment 18F-FDG PET/CT with non-metastatic TNBC were enrolled. Heterogeneity index (HI) variables derived from the metabolic tumor volume (MTV) and standardized uptake value (SUV) parameters of primary lesions were evaluated. A novel modified method introducing a percentage-based (30-40-50%) MTV slope comparison was proposed. The association between conventional 18F-FDG PET/CT parameters, HI values, and survival results was analyzed retrospectively.

Results

Tumors with higher HI values were associated with shorter survival times. For overall survival (OS), HI2 and HI3 were statistically significant (P=.009, P=.016). Regarding radiological progression-free survival (rPFS), HI1 and HI3 were statistically significant (P=.01, P=.025). A significant weak correlation between HI1 (P=.005, rho=.34) and a strong correlation was found for HI2 (P<.0001, rho=.89), HI3 and tumor size were not statistically significantly correlated (P=.063, rho=.23). T stage was statistically significantly associated with rPFS and OS (P=.038, P=.003). In contrast, no statistically significant difference was found for the N stage, anatomical, and clinical staging (P>.05).

Conclusion

This study concluded that ITH predicts survival for non-metastatic TNBC patients. This conclusion was reached with the heterogeneity index variables obtained by different methods. However, our results revealed that HI2 depends on tumor size. Our modified method (HI3) predicts survival independently of tumor size.
目的探讨非转移性三阴性乳腺癌(TNBC)患者18f -氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(18F-FDG PET/CT)成像及生存数据的半定量正电子发射断层扫描(PET)参数与瘤内异质性(ITH)的关系。方法连续纳入62例接受18F-FDG PET/CT预处理的非转移性TNBC女性患者。评估来自肿瘤代谢体积(MTV)和原发病变标准化摄取值(SUV)参数的异质性指数(HI)变量。提出了一种新的改进方法,引入基于百分比(30-40-50%)的MTV坡度比较。回顾性分析常规18F-FDG PET/CT参数、HI值与生存结果之间的关系。结果患者HI值越高,生存时间越短。总生存期(OS)方面,HI2、HI3差异有统计学意义(P= 0.009、P= 0.016)。放射学无进展生存期(rPFS)方面,HI1和HI3差异有统计学意义(P= 0.01, P= 0.025)。HI1与肿瘤大小呈显著的弱相关(P= 0.005, rho= 0.34), HI2与肿瘤大小呈显著的强相关(P= 0.0001, rho= 0.89), HI3与肿瘤大小的相关性无统计学意义(P= 0.063, rho= 0.23)。T分期与rPFS、OS相关,差异有统计学意义(P= 0.038, P= 0.003)。相比之下,N分期、解剖分期和临床分期无统计学差异(P> 0.05)。结论:ITH可预测非转移性TNBC患者的生存。这一结论是通过不同方法获得的异质性指标变量得出的。然而,我们的结果显示HI2取决于肿瘤的大小。我们改进的方法(HI3)独立于肿瘤大小预测生存。
{"title":"Nuevo método de heterogeneidad para predecir la supervivencia en el cáncer de mama triple negativo no metastásico","authors":"G.B. Babacan ,&nbsp;M.Ö. Tamam ,&nbsp;S. Saraçoğlu ,&nbsp;M.N. Acar Tayyar ,&nbsp;M.C. Şahin ,&nbsp;H. Özçevik ,&nbsp;G. Kulduk ,&nbsp;Ö.B. Ekinci ,&nbsp;E. Çelik","doi":"10.1016/j.remn.2025.500112","DOIUrl":"10.1016/j.remn.2025.500112","url":null,"abstract":"<div><h3>Objective</h3><div>This study aimed to investigate the relationship between semiquantitative positron emission tomography (PET) parameters and intratumoral heterogeneity (ITH) on <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography (<sup>18</sup>F-FDG PET/CT) imaging and survival data of non-metastatic triple-negative breast cancer (TNBC) patients.</div></div><div><h3>Methods</h3><div>Sixty-two consecutive female patients who underwent pretreatment <sup>18</sup>F-FDG PET/CT with non-metastatic TNBC were enrolled. Heterogeneity index (HI) variables derived from the metabolic tumor volume (MTV) and standardized uptake value (SUV) parameters of primary lesions were evaluated. A novel modified method introducing a percentage-based (30-40-50%) MTV slope comparison was proposed. The association between conventional <sup>18</sup>F-FDG PET/CT parameters, HI values, and survival results was analyzed retrospectively.</div></div><div><h3>Results</h3><div>Tumors with higher HI values were associated with shorter survival times. For overall survival (OS), HI2 and HI3 were statistically significant (<em>P</em>=.009, <em>P</em>=.016). Regarding radiological progression-free survival (rPFS), HI1 and HI3 were statistically significant (<em>P</em>=.01, <em>P</em>=.025). A significant weak correlation between HI1 (<em>P</em>=.005, rho=.34) and a strong correlation was found for HI2 (<em>P</em>&lt;.0001, rho=.89), HI3 and tumor size were not statistically significantly correlated (<em>P</em>=.063, rho=.23). T stage was statistically significantly associated with rPFS and OS (<em>P</em>=.038, <em>P</em>=.003). In contrast, no statistically significant difference was found for the N stage, anatomical, and clinical staging (<em>P</em>&gt;.05).</div></div><div><h3>Conclusion</h3><div>This study concluded that ITH predicts survival for non-metastatic TNBC patients. This conclusion was reached with the heterogeneity index variables obtained by different methods. However, our results revealed that HI2 depends on tumor size. Our modified method (HI3) predicts survival independently of tumor size.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 5","pages":"Article 500112"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144908672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influencia de la fiebre en el 18F-FDG PET/TC in vivo utilizando un parámetro cuantitativo SUL 使用定量参数SUL对18F-FDG PET/TC的体内发热影响
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-09-01 Epub Date: 2025-05-15 DOI: 10.1016/j.remn.2025.500127
S. Huang , M.S. Fang , M. Zhao , F. Li

Introduction

Fever can affect the identification and efficacy evaluation of tumors on the 18F-FDG PET/CT, and this effect can be reduced by referring to normal tissue metabolism.The aim of the study was to analyze the influence of fever on glucose metabolism in the mediastinal blood pool, liver, spleen, and bone marrow utilizing PET/CT quantitative parameter SUV normalized by lean body mass(SUL).

Materials and methods

30 patients with fever of unknown origin and 24 patients for tumor screening with normal body temperature within 3 weeks, who underwent 18F-FDG PET/CT in our department, were analysed retrospectively. The SULmax and SULmean of the mediastinal blood pool, liver, spleen, and bone marrow were respectively measured in the two groups, and the differences between the two groups were compared by independent sample t test or Wilcoxon-Mann-Whitney test.

Results

The SULmax and SULmean of the liver in the fever group were lower than those in the control group (P = .001, .013). The SULmax and SULmean of spleen and bone marrow in the fever group were higher than in the control group (all P < .05). The SULmax of the mediastinal blood pool in the fever group was lower than that in the control group (P = .007), but there was no significant difference in SULmean of the mediastinal between the fever group and the control group (T = 1.181, P = .221).

Conclusion

The fever can affect the glucose metabolism in internal organs. But there was no significant difference in the SULmean of mediastinal blood pool. Perhaps the SULmean of the blood pool can be invoked as a calibration parameter in the evaluation of efficacy in tumor patients with fever.
发热会影响肿瘤在18F-FDG PET/CT上的识别和疗效评价,参照正常组织代谢可以降低这种影响。本研究的目的是利用PET/CT定量参数SUV标准化瘦体质量(SUL)分析发热对纵隔血池、肝脏、脾脏和骨髓中葡萄糖代谢的影响。材料与方法回顾性分析我科在3周内行18F-FDG PET/CT检查的30例不明原因发热患者和24例体温正常的肿瘤筛查患者。分别测定两组纵隔血池、肝脏、脾脏、骨髓的SULmax和SULmean,采用独立样本t检验或Wilcoxon-Mann-Whitney检验比较两组间的差异。结果发热组肝脏SULmax、SULmean均低于对照组(P = 0.001、0.013)。发热组脾、骨髓SULmax、SULmean均高于对照组(P < 0.05)。发热组纵隔血池SULmax低于对照组(P = 0.007),而发热组纵隔血池SULmax与对照组比较差异无统计学意义(T = 1.181, P = 0.221)。结论发热可影响脏器糖代谢。两组纵隔血池sul均值差异无统计学意义。或许血池SULmean可以作为肿瘤发热患者疗效评价的校准参数。
{"title":"Influencia de la fiebre en el 18F-FDG PET/TC in vivo utilizando un parámetro cuantitativo SUL","authors":"S. Huang ,&nbsp;M.S. Fang ,&nbsp;M. Zhao ,&nbsp;F. Li","doi":"10.1016/j.remn.2025.500127","DOIUrl":"10.1016/j.remn.2025.500127","url":null,"abstract":"<div><h3>Introduction</h3><div>Fever can affect the identification and efficacy evaluation of tumors on the <sup>18</sup>F-FDG PET/CT, and this effect can be reduced by referring to normal tissue metabolism.The aim of the study was to analyze the influence of fever on glucose metabolism in the mediastinal blood pool, liver, spleen, and bone marrow utilizing PET/CT quantitative parameter SUV normalized by lean body mass(SUL).</div></div><div><h3>Materials and methods</h3><div>30 patients with fever of unknown origin and 24<!--> <!-->patients for tumor screening with normal body temperature within 3<!--> <!-->weeks, who underwent <sup>18</sup>F-FDG PET/CT in our department, were analysed retrospectively. The SUL<sub>max</sub> and SUL<sub>mean</sub> of the mediastinal blood pool, liver, spleen, and bone marrow were respectively measured in the two groups, and the differences between the two groups were compared by independent sample t test or Wilcoxon-Mann-Whitney test.</div></div><div><h3>Results</h3><div>The SUL<sub>max</sub> and SUL<sub>mean</sub> of the liver in the fever group were lower than those in the control group (<em>P</em> <!-->=<!--> <!-->.001, .013). The SUL<sub>max</sub> and SUL<sub>mean</sub> of spleen and bone marrow in the fever group were higher than in the control group (all <em>P</em> <!-->&lt;<!--> <!-->.05). The SUL<sub>max</sub> of the mediastinal blood pool in the fever group was lower than that in the control group (<em>P</em> <!-->=<!--> <!-->.007), but there was no significant difference in SUL<sub>mean</sub> of the mediastinal between the fever group and the control group (T<!--> <!-->=<!--> <!-->1.181, <em>P</em> <!-->=<!--> <!-->.221).</div></div><div><h3>Conclusion</h3><div>The fever can affect the glucose metabolism in internal organs. But there was no significant difference in the SUL<sub>mean</sub> of mediastinal blood pool. Perhaps the SUL<sub>mean</sub> of the blood pool can be invoked as a calibration parameter in the evaluation of efficacy in tumor patients with fever.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 5","pages":"Article 500127"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144908539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Importancia pronóstica de las distancias normalizadas entre el punto de captación máxima estandarizado del radiotrazador y el centro tumoral en la PET/TC con 18F-FDG en el carcinoma de células escamosas de cabeza y cuello 在头颈部鳞状细胞癌中,使用18F-FDG的PET/ CT中,标准放射示踪剂的最大采集点与肿瘤中心之间标准化距离的预测重要性
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-07-01 Epub Date: 2025-05-12 DOI: 10.1016/j.remn.2025.500103
S.-P. Hong , S.M. Lee , I.D. Yoo , I.Y. Jo , Y.K. Won , M.-S. Kim , H.J. Choi , J. Won Lee , S.J. Jang

Objective

The maximum 18F-FDG uptake of a cancer lesion has been found to relocate from the center to the periphery during progression. This behavior proposes that the normalized distances from the hotspot of radiotracer uptake to the tumor centroid (NHOC) and to the tumor perimeter (NHOP) could serve as novel geometric PET parameters indicative of tumor aggressiveness. This study aimed to explore the prognostic relevance of NHOC and NHOP in 18F-FDG PET/CT for predicting the response to concurrent chemoradiotherapy (CCRT) and progression-free survival (PFS) in patients with head and neck squamous cell carcinoma.

Materials and methods

We retrospectively reviewed 116 head and neck squamous cell carcinoma patients who received CCRT and were assessed with pre-treatment (PET1) and 3 months post-treatment PET/CT (PET2). Along with conventional PET parameters, NHOC and NHOP for primary tumors on PET1 and the percent changes in NHOC and NHOP between PET1 and PET2 were measured.

Results

Of all the PET1 parameters assessed, NHOC was the most effective in predicting the CCRT response, achieving an area under the receiver operating characteristic curve of 0.645. In multivariate logistic regression and survival analysis, NHOC identified as an independent predictor for both complete metabolic response (p = 0.028) and PFS (p = 0.006). In a subgroup of 46 patients exhibiting residual primary tumors on PET2, both the percent changes in NHOC (p = 0.048) and NHOP (p = 0.041) were significantly associated with PFS.

Conclusions

NHOC and the percent changes in NHOC and NHOP following CCRT may serve as effective 18F-FDG PET/CT parameters for predicting clinical outcomes in head and neck squamous cell carcinoma patients.
目的发现在肿瘤进展过程中,18F-FDG的最大摄取从中心向外周转移。这种行为表明,从放射性示踪剂摄取热点到肿瘤质心(NHOC)和肿瘤周长(NHOP)的归一化距离可以作为指示肿瘤侵袭性的新型几何PET参数。本研究旨在探讨NHOC和NHOP在18F-FDG PET/CT中预测头颈部鳞状细胞癌患者同步放化疗(CCRT)反应和无进展生存期(PFS)的预后相关性。材料与方法我们回顾性分析116例接受CCRT治疗的头颈部鳞状细胞癌患者,并对治疗前(PET1)和治疗后3个月的PET/CT (PET2)进行评估。在常规PET参数的基础上,测定PET1上原发肿瘤的NHOC和NHOP,以及PET1和PET2之间NHOC和NHOP的变化百分比。结果在所有评估的PET1参数中,NHOC预测CCRT反应最有效,其在受试者工作特征曲线下的面积为0.645。在多变量logistic回归和生存分析中,NHOC被确定为完全代谢反应(p = 0.028)和PFS (p = 0.006)的独立预测因子。在一个由46名在PET2上显示残留原发肿瘤的患者组成的亚组中,NHOC (p = 0.048)和NHOP (p = 0.041)的百分比变化与PFS显著相关。结论CCRT后snhoc及NHOC和NHOP百分比变化可作为预测头颈部鳞状细胞癌患者临床预后的有效18F-FDG PET/CT参数。
{"title":"Importancia pronóstica de las distancias normalizadas entre el punto de captación máxima estandarizado del radiotrazador y el centro tumoral en la PET/TC con 18F-FDG en el carcinoma de células escamosas de cabeza y cuello","authors":"S.-P. Hong ,&nbsp;S.M. Lee ,&nbsp;I.D. Yoo ,&nbsp;I.Y. Jo ,&nbsp;Y.K. Won ,&nbsp;M.-S. Kim ,&nbsp;H.J. Choi ,&nbsp;J. Won Lee ,&nbsp;S.J. Jang","doi":"10.1016/j.remn.2025.500103","DOIUrl":"10.1016/j.remn.2025.500103","url":null,"abstract":"<div><h3>Objective</h3><div>The maximum <sup>18</sup>F-FDG uptake of a cancer lesion has been found to relocate from the center to the periphery during progression. This behavior proposes that the normalized distances from the hotspot of radiotracer uptake to the tumor centroid (NHOC) and to the tumor perimeter (NHOP) could serve as novel geometric PET parameters indicative of tumor aggressiveness. This study aimed to explore the prognostic relevance of NHOC and NHOP in <sup>18</sup>F-FDG PET/CT for predicting the response to concurrent chemoradiotherapy (CCRT) and progression-free survival (PFS) in patients with head and neck squamous cell carcinoma.</div></div><div><h3>Materials and methods</h3><div>We retrospectively reviewed 116 head and neck squamous cell carcinoma patients who received CCRT and were assessed with pre-treatment (PET1) and 3 months post-treatment PET/CT (PET2). Along with conventional PET parameters, NHOC and NHOP for primary tumors on PET1 and the percent changes in NHOC and NHOP between PET1 and PET2 were measured.</div></div><div><h3>Results</h3><div>Of all the PET1 parameters assessed, NHOC was the most effective in predicting the CCRT response, achieving an area under the receiver operating characteristic curve of 0.645. In multivariate logistic regression and survival analysis, NHOC identified as an independent predictor for both complete metabolic response (p<!--> <!-->=<!--> <!-->0.028) and PFS (p<!--> <!-->=<!--> <!-->0.006). In a subgroup of 46 patients exhibiting residual primary tumors on PET2, both the percent changes in NHOC (p<!--> <!-->=<!--> <!-->0.048) and NHOP (p<!--> <!-->=<!--> <!-->0.041) were significantly associated with PFS.</div></div><div><h3>Conclusions</h3><div>NHOC and the percent changes in NHOC and NHOP following CCRT may serve as effective <sup>18</sup>F-FDG PET/CT parameters for predicting clinical outcomes in head and neck squamous cell carcinoma patients.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 4","pages":"Article 500103"},"PeriodicalIF":1.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144557566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Síndrome de activación macrofágica en un paciente pediátrico: hallazgos en PET/TC con 18F-FDG 儿科患者巨噬细胞活化综合征:PET/ CT与18F-FDG的发现
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-07-01 Epub Date: 2025-06-19 DOI: 10.1016/j.remn.2025.500183
J.P. Suárez Fernández, M.L. Domínguez Grande, C. Vigil Díaz, B. Fernández Llana, N. Martín Fernández, F.M. González García
{"title":"Síndrome de activación macrofágica en un paciente pediátrico: hallazgos en PET/TC con 18F-FDG","authors":"J.P. Suárez Fernández,&nbsp;M.L. Domínguez Grande,&nbsp;C. Vigil Díaz,&nbsp;B. Fernández Llana,&nbsp;N. Martín Fernández,&nbsp;F.M. González García","doi":"10.1016/j.remn.2025.500183","DOIUrl":"10.1016/j.remn.2025.500183","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 4","pages":"Article 500183"},"PeriodicalIF":1.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144557694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utilidad de la PET/TC con [18F]FDG más allá de la estadificación: importancia pronóstica de la sarcopenia y del metabolismo del tejido adiposo en el carcinoma esofágico PET/ CT与[18F]FDG的应用超越了确定阶段:在食管癌中减少结节和脂肪组织代谢的预后重要性
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-07-01 Epub Date: 2025-06-24 DOI: 10.1016/j.remn.2024.500090
M.N. Acar Tayyar , M. Öner Tamam , G. Buğrahan Babacan , M. Can Şahin , H. Özçevik , N. Gürdal , K. Atakır

Aim

This study aimed to investigate the relationship between PET and CT parameters and sarcopenia, adipose tissue, and tumor metabolism in esophageal carcinoma (EC) and its impact on survival in EC.

Method

Our study included 122 EC patients who underwent PET/CT for staging. Muscle and adipose tissue characteristics were evaluated, including lumbar (L3) and cervical (C3) muscle areas, psoas major (PM) and sternocleidomastoid muscle (SCM) parameters, and PET parameters for visceral and subcutaneous adipose tissue (SAT). Sarcopenia was determined using CT images, with a threshold for muscle tissue at the L3 vertebral level, and its impact on overall survival (OS) was investigated.

Results

Sarcopenia was detected in 48 patients. SULmax in the primary tumor (PT) was significantly higher in sarcopenic patients (SP). The frequency of distant metastasis was higher in SP and OS was significantly lower. In the locally advanced stage, sarcopenia status decreased survival. L3, PM, C3, and SCM muscle areas were highly correlated. Subcutaneous adipose tissue SUVmax was significantly increased in SP and those with distant metastasis. Univariate analysis identified PT SULmax, PT SUVmean, PT TLG, lymph node and distant metastasis, SAT SUVmax, and sarcopenia as poor prognostic factors, while multivariate analysis confirmed BMI, distant metastasis, PT SUVmean, PT TLG as independent predictors of OS.

Conclusion

This study demonstrated that sarcopenia, linked to reduced survival, correlates with primary tumor SULmax, distant metastasis, and subcutaneous tissue PET parameters, exerting a notable impact on survival, particularly in locally advanced stages. Attenuation-corrected CT can be used instead of diagnostic CT, and sarcopenia can be diagnosed using not only L3 but also C3 slices.
目的探讨PET、CT参数与食管癌(EC)肌肉减少症、脂肪组织及肿瘤代谢的关系及其对生存的影响。方法122例EC患者行PET/CT分期。评估肌肉和脂肪组织特征,包括腰椎(L3)和颈椎(C3)肌肉区域、腰肌(PM)和胸锁乳突肌(SCM)参数,以及内脏和皮下脂肪组织(SAT)的PET参数。使用CT图像确定肌肉减少症,并在L3椎体水平设置肌肉组织阈值,并研究其对总生存期(OS)的影响。结果48例患者出现肌肉减少症。原发性肿瘤患者(PT)的SULmax明显高于肌肉减少症患者(SP)。SP的远处转移频率较高,OS的远处转移频率明显较低。在局部晚期,肌少症状态降低了生存率。L3、PM、C3和SCM肌区高度相关。皮下脂肪组织SUVmax在SP和远处转移患者中显著增加。单因素分析发现PT SULmax、PT SUVmean、PT TLG、淋巴结和远处转移、SAT SUVmax和肌肉减少症是不良预后因素,多因素分析证实BMI、远处转移、PT SUVmean、PT TLG是OS的独立预测因素。本研究表明,肌肉减少症与生存率降低有关,与原发肿瘤SULmax、远处转移和皮下组织PET参数相关,对生存率有显著影响,特别是在局部晚期。可以使用衰减校正CT代替诊断性CT,不仅可以使用L3片,还可以使用C3片诊断肌肉减少症。
{"title":"Utilidad de la PET/TC con [18F]FDG más allá de la estadificación: importancia pronóstica de la sarcopenia y del metabolismo del tejido adiposo en el carcinoma esofágico","authors":"M.N. Acar Tayyar ,&nbsp;M. Öner Tamam ,&nbsp;G. Buğrahan Babacan ,&nbsp;M. Can Şahin ,&nbsp;H. Özçevik ,&nbsp;N. Gürdal ,&nbsp;K. Atakır","doi":"10.1016/j.remn.2024.500090","DOIUrl":"10.1016/j.remn.2024.500090","url":null,"abstract":"<div><h3>Aim</h3><div>This study aimed to investigate the relationship between PET and CT parameters and sarcopenia, adipose tissue, and tumor metabolism in esophageal carcinoma (EC) and its impact on survival in EC.</div></div><div><h3>Method</h3><div>Our study included 122 EC patients who underwent PET/CT for staging. Muscle and adipose tissue characteristics were evaluated, including lumbar (L3) and cervical (C3) muscle areas, psoas major (PM) and sternocleidomastoid muscle (SCM) parameters, and PET parameters for visceral and subcutaneous adipose tissue (SAT). Sarcopenia was determined using CT images, with a threshold for muscle tissue at the L3 vertebral level, and its impact on overall survival (OS) was investigated.</div></div><div><h3>Results</h3><div>Sarcopenia was detected in 48 patients. SULmax in the primary tumor (PT) was significantly higher in sarcopenic patients (SP). The frequency of distant metastasis was higher in SP and OS was significantly lower. In the locally advanced stage, sarcopenia status decreased survival. L3, PM, C3, and SCM muscle areas were highly correlated. Subcutaneous adipose tissue SUVmax was significantly increased in SP and those with distant metastasis. Univariate analysis identified PT SULmax, PT SUVmean, PT TLG, lymph node and distant metastasis, SAT SUVmax, and sarcopenia as poor prognostic factors, while multivariate analysis confirmed BMI, distant metastasis, PT SUVmean, PT TLG as independent predictors of OS.</div></div><div><h3>Conclusion</h3><div>This study demonstrated that sarcopenia, linked to reduced survival, correlates with primary tumor SULmax, distant metastasis, and subcutaneous tissue PET parameters, exerting a notable impact on survival, particularly in locally advanced stages. Attenuation-corrected CT can be used instead of diagnostic CT, and sarcopenia can be diagnosed using not only L3 but also C3 slices.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 4","pages":"Article 500090"},"PeriodicalIF":1.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144557697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PET/TC con 18F-FDG de doble tiempo en un caso de linfoma extranodal primario hepático de zona marginal del tejido linfoide asociado a mucosa 在粘膜相关淋巴组织边缘区原发性肝样外淋巴瘤病例中,PET/TC加18F-FDG两次
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-07-01 Epub Date: 2025-04-28 DOI: 10.1016/j.remn.2025.500105
R. Yang, Z. Zheng, Y. Lin, H. Shi
{"title":"PET/TC con 18F-FDG de doble tiempo en un caso de linfoma extranodal primario hepático de zona marginal del tejido linfoide asociado a mucosa","authors":"R. Yang,&nbsp;Z. Zheng,&nbsp;Y. Lin,&nbsp;H. Shi","doi":"10.1016/j.remn.2025.500105","DOIUrl":"10.1016/j.remn.2025.500105","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 4","pages":"Article 500105"},"PeriodicalIF":1.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144557568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluación del angiosarcoma cardíaco mediante [18F]FDG PET/TC 使用[18F]FDG PET/TC评估心脏血管肉瘤
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-07-01 Epub Date: 2025-04-02 DOI: 10.1016/j.remn.2025.500131
B. Hervás-Sanz , N. Ruiz-Roig , L. Rodríguez-Bel , L.M. Gràcia-Sánchez , M. Cortés-Romera , P.C. Notta
{"title":"Evaluación del angiosarcoma cardíaco mediante [18F]FDG PET/TC","authors":"B. Hervás-Sanz ,&nbsp;N. Ruiz-Roig ,&nbsp;L. Rodríguez-Bel ,&nbsp;L.M. Gràcia-Sánchez ,&nbsp;M. Cortés-Romera ,&nbsp;P.C. Notta","doi":"10.1016/j.remn.2025.500131","DOIUrl":"10.1016/j.remn.2025.500131","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 4","pages":"Article 500131"},"PeriodicalIF":1.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144563896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PET/TC con [18F]FDG en el diagnóstico y evaluación de respuesta al tratamiento en un paciente con sarcoidosis sistémica PET/ CT与[18F]FDG在全身性结节病患者治疗反应的诊断和评估
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-07-01 Epub Date: 2025-04-07 DOI: 10.1016/j.remn.2025.500135
J.P. Suárez Fernández, S. Naranjo Sancho, M.L. Domínguez Grande, C. Vigil Díaz, N. Martín Fernández, F.M. González García
{"title":"PET/TC con [18F]FDG en el diagnóstico y evaluación de respuesta al tratamiento en un paciente con sarcoidosis sistémica","authors":"J.P. Suárez Fernández,&nbsp;S. Naranjo Sancho,&nbsp;M.L. Domínguez Grande,&nbsp;C. Vigil Díaz,&nbsp;N. Martín Fernández,&nbsp;F.M. González García","doi":"10.1016/j.remn.2025.500135","DOIUrl":"10.1016/j.remn.2025.500135","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 4","pages":"Article 500135"},"PeriodicalIF":1.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144557693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista Espanola De Medicina Nuclear E Imagen Molecular
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1